The federal right to try act of 2017—A wrong turn for access to investigational drugs and the path forward

Alison Bateman-House, Christopher T Robertson

Research output: Contribution to journalComment/debate

11 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)321-322
Number of pages2
JournalJAMA Internal Medicine
Volume178
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Investigational Drugs

ASJC Scopus subject areas

  • Internal Medicine

Cite this

The federal right to try act of 2017—A wrong turn for access to investigational drugs and the path forward. / Bateman-House, Alison; Robertson, Christopher T.

In: JAMA Internal Medicine, Vol. 178, No. 3, 01.03.2018, p. 321-322.

Research output: Contribution to journalComment/debate

@article{b7cae2eca3eb40898b62878c8701073c,
title = "The federal right to try act of 2017—A wrong turn for access to investigational drugs and the path forward",
author = "Alison Bateman-House and Robertson, {Christopher T}",
year = "2018",
month = "3",
day = "1",
doi = "10.1001/jamainternmed.2017.8167",
language = "English (US)",
volume = "178",
pages = "321--322",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - The federal right to try act of 2017—A wrong turn for access to investigational drugs and the path forward

AU - Bateman-House, Alison

AU - Robertson, Christopher T

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85042904792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042904792&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2017.8167

DO - 10.1001/jamainternmed.2017.8167

M3 - Comment/debate

C2 - 29356821

AN - SCOPUS:85042904792

VL - 178

SP - 321

EP - 322

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 3

ER -